ReviewClinical pharmacology : advances and applications2016

LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives.

Farzaneh Atashrazm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.